Skip to main content

Diabetic Microvascular Disease

Hardcover

Pre-order

$199.95

Diabetic Microvascular Disease

Francesco Tecilazich

ISBN: 978-1-119-30960-4 December 2019 Wiley-Blackwell 600 Pages

Hardcover
Pre-order
$199.95

Description

Diabetes remains one of the main causes, in the western world, of legal blindness, end stage renal disease, and amputation, despite the implementation of tight glycemic control and the great progress in the management and care of our patients.

In the perspective that clinical and basic-science knowledge are fundamental to clinicians as well as to researchers, this book is a valuable resource by integrating clinical information and research frontlines of the microvascular complications of diabetes.

It will provide up-to-date diagnostic criteria, classifications, and therapeutic approaches and recent discoveries on mechanisms of disease, experimental therapeutic agents, and biomarkers of disease.

The ultimate goal of this book is to provide a useful and handy tool to professionals and students in the field of diabetes and its microvascular complications.

1. Diabetes Mellitus
General Aspects
Complications

2. Diabetic Microvascular Disease
Pathophysiology
Anatomopathology

3. Genetics and Epigenetics of Diabetic Microvascular Disease

4. Immunity and Diabetic Microvascular disease

5. Diabetic Retinopathy
Clinical aspects
Research

6. Diabetic Nephropathy
Clinical aspects
Research

7. Diabetic Neuropathy
Clinical aspects
Research

8. Diabetic Foot
Clinical aspects
Research

9. Heart
Clinical aspects
Research

10. Brain
Clinical aspects
Research

11. The Urge for a Biomarker of Risk

Tentative list of contributors:

Francesco Bandello, MD, San Raffaele Hospital, Vita Salute University, Milan, Italy
Zeina Dagher‐Mansour, PhD, Schepens Eye Research Institute and Massachusetts General Hospital, Harvard Medical School Andre Dejam, MD, PhD, Harvard Vanguard Medical Associates, Boston
Alessandro Doria, MD, PhD, Joslin Diabetes Center, Harvard Medical School and Harvard School of Public Health
Cristopher Gibbons, MD, MMS, Beth Israel Deaconess Medical Center, Harvard Medical School
Luisa Giusti del Giardino, MD, San Raffaele Hospital, Vita Salute University, Milan, Italy
Gopalan Gnanaguru, PhD, Schepens Eye Research Institute, Harvard Medical School Luigi Gnudi, MD, PhD, Guys Hospital, King's College, London, UK
Antonio Kafanas, MD, PhD
Mara Lorenzi, MD, Schepens Eye Research Institute, Harvard Medical School
Ashley Mackey, PhD, Schepens Eye Research Institute, Harvard Medical School James Meigs, MD, Massachusetts General Hospital, Harvard Medical School
Cristian Nicoletti, MD, Pederzoli Hospital, Verona, Italy
Ali Poyer‐Mehr, MD, PhD, Beth Israel Deaconess Medical Center, Harvard Medical School
Giulio Romeo, MD, PhD, Joslin Diabetes Center, Harvard Medical School,
Aristidis Veves, MD, MSc, Beth Israel Deaconess Medical Center, Harvard Medical School
Gianpaolo Zerbini, MD, PhD, San Raffaele Hospital, Vita Salute University, Milan, Italy